We are not supporting this browser

Nutrison Diason Energy HP

A unique tube feed specifically designed for patients with hyperglycaemia

nutrison diason energy hp launch campaign page1 image

Inpatients are at risk of poor glycaemic control1,2

Nutritional support strategies for patients with hyperglycaemia

nutrison diason energy hp launch campaign page3 image2

Enteral tube feeds have been found to produce a more rapid rise in blood glucose levels than a nutritionally equivalent solid meal.

nutrison diason energy hp launch campaign page4 image1 v2

Controlling blood glucose levels may improve patient outcomes - patient safety and cost4,5

Causes of hyperglycaemia

The underlying cause of hyperglycaemia is usually loss of insulin producing cells in the pancreas or development of resistance to insulin

Contributing factors of hyperglycaemia

  1. Missing a dose of diabetic medication, tablets or insulin5
  2. New medication or change in medication, e.g. steroids5
  3. Overfeeding6
  4. Stress - physical (e.g. an injury or surgery), mental or emotional
  5. Infection of illness7

Symptoms of hyperglycaemia

nutrison diason energy hp launch campaign page4 image

Patient types at risk of hyperglycaemia

nutrison diason energy hp launch campaign page5 image

The impact of hyperglycaemia16-18

nutrison diason energy hp launch campaign page6 image

Managing tube fed patients with hyperglycaemia

Multidisciplinary team approach

nutrison diason energy hp launch campaign page7 image

Goals of dietetic intervention:

  • Prioritise meeting the patient's nutritional requirements
  • Monitor carbohydrate intake
  • Communicate with the multidisciplary team
  • Switch feeding method - bolus vs continuous
  • Trying a slower feeding rate
  • Try a high protein or high fibre tube feed

What are diabetes specific formulas?16-18

nutrison diason energy hp launch campaign page10 image

Clinical benefits of diabetes specific formulas

nutrison diason energy hp launch campaign page11 image


Cost saving benefits of diabetes specific formulas


A UNIQUE tube feed designed for patients with hyperglycaemia

*Isomaltulose has a slow hydrolysis rate resulting in a reduced glucose and insulin response24
**A mixture of soluble and insoluble fibres to help maintain gut health including gut integrity and bowel function25
nutrison diason energy hp launch campaign page 13 image
nutrison diason energy hp launch campaign nutritional breakdown image

Nutrison Diason Energy HP has been proven to improve glucose levels23

nutrison diason energy hp launch campaign page14 image
nutrison diason energy hp launch campaign page16 image2
  1. World Health Organization, 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia.
  2. Gandy J. 2015. Manual of Dietetic Practice.
  3. Pancorbo-Hidalgo PL, et al. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001; 10(4):482-90.
  4. McMahon MM, et al. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013; 37(1):23-36. https://aspenjournals.onlinelibrary.wiley.com/doi epdf/10.1177/0148607112452001
  5. Davidson P, et al. Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient. Nutr Clin Pract. 2015; 30(5):652-9.
  6. González Infantino CA, et al. Hyperglycemia and hypoalbuminemia as prognostic mortality factors in patients with enteral feeding. Nutrition. 2013; 29(3):497-501.
  7. Meizoso JP, et al. Admission hyperglycemia is associated with different outcomes after blunt versus penetrating trauma. J Surg Res. 2016; 206(1):83-9.
  8. Honiden S, et al. Metabolic Management during Critical Illness: Glycemic Control in the ICU. Semin Respir Crit Care Med. 2015; 36(6):859-69. https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0035-1565253.pdf
  9. Plummer MP, et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. 2014; 40(7):973-80.
  10. Umpierrez GE, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87(3):978-82. https://academic.oup.com/jcem/article/87/3/978/2846522
  11. Hwangbo Y, et al. Acute Hyperglycemia Associated with Anti-Cancer Medication. Endocrinol Metab (Seoul). 2017; 32(1):23-9. https://www.e-enm.org/upload/pdf/enm-32-23.pdf
  12. Habib SL, et al. Diabetes and risk of cancer. ISRN Oncology. 2013; 2013:583786.
  13. National Diabetes Audit, 2017.
  14. Lau LH, et al. Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J Diabetes Investig. 2019; 10(3):780-92. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.12932
  15. Mi D, et al. Correlation of hyperglycemia with mortality after acute ischemic stroke. Ther Adv Neurol Disord. 2017; 11:1756285617731686. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784549/
  16. Elia M, et al. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005; 28(9):2267-79. https://care.diabetesjournals.org/content/28/9/2267.long
  17. Ojo O, et al. Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients. 2014; 6(11):5142-52. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245584/
  18. American Diabetes Association. Diabetes Care in the Hospital. Diabetes Care. 2017; 40(Suppl 1).
  19. Sanz-París A, et al. Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia. A systematic review and meta-analysis. Clin Nutr. 2020; 39(11):3273-82.
  20. Hamdy O, et al. Differences in resource utilization between patients with diabetes receiving glycemia-targeted specialized nutrition vs standard nutrition formulas in U.S. hospitals. JPEN J Parenter Enteral Nutr. 2014; 38(2 Suppl):86s-91s.
  21. Han YY, et al. The clinical and economic impact of the use of diabetes-specific enteral formula on ICU patients with type 2 diabetes. Clin Nutr. 2017; 36(6):1567-72.
  22. Barazzoni R, et al. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. Clin Nutr. 2017; 36(2):355-63.
  23. Lansink M, et al. Improved Glucose Profile in Patients With Type 2 Diabetes With a New, High-Protein, Diabetes-Specific Tube Feed During 4 Hours of Continuous Feeding. JPEN J Parenter Enteral Nutr. 2017; 41(6):968-75.
  24. Lina BAR, et al. Isomaltulose (Palatinose®): a review of biological and toxicological studies. Food and Chemical Toxicology. 2002; 40(10):1375-81.
  25. Green CJ. Fibre in enteral nutrition. Clinical Nutrition. 2001; 20(1):23-39.

Nutrison Diason Energy HP is a Food for Special Medical Purposes for the dietary management of disease related malnutrition in patients with diabetes mellitus and/or hyperglycaemia with higher energy and protein needs, and must be used under medical supervision.

Nutricia uses cookies on this website. With your consent we will use them to measure and analyze usage of the website (analytical cookies), to tailor it to your interests (personalisational cookies), and to present you relevant advertising and information (targeting cookies). For more information please read the cookie policy.

Privacy Settings

You can choose your preferences anytime for cookies and tracking. For more information please read our cookie policy.

  • Strictly necessary

    They are necessary for the website to function and cannot be switched off. They are usually only set in response to actions made by you which amount to a request for services (setting your privacy preferences, logging in, filling in forms, etc.). You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.

  • Analytical cookies

    They allow us to count visits and traffic sources, to measure and improve the performance of our site. They show us which pages are the most and least popular and how visitors move around the site. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

  • Personalisation cookies

    They enable website’s enhanced functionality and personalisation. They may be set by us or by third parties whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

  • Targeting cookies

    They may be set through our site by our advertising partners, to build a profile of your interests and to show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.